Apimostinel

N/A

Report date: 2025/09/25 20:00:07
NME

Base Information

Drug NameApimostinel
Drug Alias NameNRX-1074AGN-241660GATE-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor agonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNaurex, Inc, An Affiliate Of Allergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesGate Neurosciences Inc
Inactive CompaniesNaurex, Inc, An Affiliate Of Allergan Plc
Active IndicationsDepressive Disorder, Major
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A